Copley Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Copley Financial Group's ABBV Position: Q3 2026 in Review
Copley Financial Group sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 1,092 shares — an estimated $275K sold.
Copley Financial Group first reported a position in ABBV in Q3 2024 and held it in 8 quarters. The position peaked at $523K in Q1 2025. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Copley Financial Group reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
- Copley Financial Group sold 1,092 AbbVie shares in Q3 2026, an estimated $275K.
- Copley Financial Group first reported a position in AbbVie in Q3 2024 and held it in 8 quarters.
- Copley Financial Group's AbbVie position peaked at $523K in Q1 2025.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Copley Financial Group's 13F filing for Q3 2026, filed 16 Nov 2026.